Physician profile
Richard Lebowitz
NPI 1285653832
$8,369.65
in general payments reported to CMS, 2019-2025
14 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $552 · 2021: $3,893 · 2022: $371 · 2023: $494 · 2024: $1,985 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Consulting Fee: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.92 |
| Consulting Fee | $1,304.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metrex Research, LLC | $2,990.00 | 2021 | |
| Acclarent, INC | $1,899.90 | 2019-2023 | Trudi Nav Cable |
| Genzyme Corporation | $1,613.24 | 2021-2024 | |
| Intersect Ent, INC. | $566.37 | 2019-2021 | |
| Stryker Corporation | $420.06 | 2019-2025 | Adherus Autospray Dural Sealant, Universal Neuro 3, Direct Inject |
| Neurent Medical Limited | $175.00 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Optinose US, INC. | $148.83 | 2020-2024 | |
| Aerin Medical INC. | $135.63 | 2023 | |
| Spirair, INC. | $129.13 | 2025 | |
| Integra Lifesciences Corporation | $92.43 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic USA, INC. | $78.12 | 2019-2020 | |
| Medtronic, INC. | $56.61 | 2024 | Pteye Parathyroid Detection System |
| Baxter Healthcare | $39.69 | 2021 | |
| Glaxosmithkline, LLC. | $24.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Lebowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.